应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
00660 玮俊生物科技
未开盘 02-27 09:20:35
0.260
+0.000
0.00%
最高
0.260
最低
0.260
成交量
0.00
今开
0.260
昨收
0.260
日振幅
0.00%
总市值
4,628万
流通市值
4,628万
总股本
1.78亿
成交额
0.00
换手率
0.00%
流通股本
1.78亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
玮俊生物科技(00660)发布中期业绩,股东应占亏损593.9万港元 同比减少56.53%
智通财经 · 02-27 18:24
玮俊生物科技(00660)发布中期业绩,股东应占亏损593.9万港元 同比减少56.53%
瑋俊生物科技2026财年上半年营收3.52亿元,经调整净亏损0.06亿元
公告速递 · 02-27 18:21
瑋俊生物科技2026财年上半年营收3.52亿元,经调整净亏损0.06亿元
玮俊生物科技盘中异动 急速下跌7.14%报0.260港元
市场透视 · 02-26
玮俊生物科技盘中异动 急速下跌7.14%报0.260港元
玮俊生物科技(00660.HK):预计中期净亏损不超过600万港元 同比大幅减少
中金财经 · 02-25
玮俊生物科技(00660.HK):预计中期净亏损不超过600万港元 同比大幅减少
玮俊生物科技中期业绩预增 主因营收上升与财务成本下降
美股速递 · 02-25
玮俊生物科技中期业绩预增 主因营收上升与财务成本下降
瑋俊生物科技有限公司2025年下半年营收上升,净利润-6.0百万港元
公告速递 · 02-25
瑋俊生物科技有限公司2025年下半年营收上升,净利润-6.0百万港元
玮俊生物科技(00660)及第一被告已向香港高等法院提交上诉通知书
智通财经 · 02-25
玮俊生物科技(00660)及第一被告已向香港高等法院提交上诉通知书
玮俊生物科技:法院判决公司及首名被告各向Island Sky支付270万港元
美股速递 · 02-25
玮俊生物科技:法院判决公司及首名被告各向Island Sky支付270万港元
玮俊生物科技有限公司正寻求法律咨询以确定潜在行动方案
美股速递 · 02-25
玮俊生物科技有限公司正寻求法律咨询以确定潜在行动方案
玮俊生物科技盘中异动 股价大涨9.62%
市场透视 · 02-24
玮俊生物科技盘中异动 股价大涨9.62%
玮俊生物科技(00660.HK)拟2月27日举行董事会会议批准中期业绩
中金财经 · 02-12
玮俊生物科技(00660.HK)拟2月27日举行董事会会议批准中期业绩
玮俊生物科技盘中异动 股价大跌8.64%
市场透视 · 01-26
玮俊生物科技盘中异动 股价大跌8.64%
玮俊生物科技盘中异动 股价大跌5.58%报0.220港元
市场透视 · 01-21
玮俊生物科技盘中异动 股价大跌5.58%报0.220港元
玮俊生物科技盘中异动 临近午盘大幅下挫12.07%报0.204港元
市场透视 · 01-20
玮俊生物科技盘中异动 临近午盘大幅下挫12.07%报0.204港元
瑋俊生物科技(660)拟回购最多10%股份
公告速递 · 2025-12-05
瑋俊生物科技(660)拟回购最多10%股份
瑋俊生物科技(00660)2025年11月股份變動月報表,完成股本面值削減
公告速递 · 2025-12-04
瑋俊生物科技(00660)2025年11月股份變動月報表,完成股本面值削減
瑋俊生物科技(660)股本重组生效并完成可换股债券条款修订
公告速递 · 2025-11-19
瑋俊生物科技(660)股本重组生效并完成可换股债券条款修订
玮俊生物科技盘中异动 早盘大幅拉升22.55%
市场透视 · 2025-11-19
玮俊生物科技盘中异动 早盘大幅拉升22.55%
玮俊生物科技盘中异动 临近午盘股价大涨6.12%
市场透视 · 2025-11-17
玮俊生物科技盘中异动 临近午盘股价大涨6.12%
玮俊生物科技盘中异动 股价大跌6.98%
市场透视 · 2025-11-03
玮俊生物科技盘中异动 股价大跌6.98%
加载更多
公司概况
公司名称:
玮俊生物科技
所属市场:
SEHK
上市日期:
--
主营业务:
玮俊生物科技有限公司是一家主要从事制造及销售变性淀粉的香港投资控股公司。该公司连同其附属公司主要从事制造及销售变性淀粉及其他生化产品,例如生化精炼油产品。此外,该公司还从事买卖电子元件、组件和器件及电器。
发行价格:
--
{"stockData":{"symbol":"00660","market":"HK","secType":"STK","nameCN":"玮俊生物科技","latestPrice":0.26,"timestamp":1772155235030,"preClose":0.26,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":178000000,"shares":178000000,"eps":-0.084305,"marketStatus":"未开盘","change":0,"latestTime":"02-27 09:20:35","open":0.26,"high":0.26,"low":0.26,"amount":0,"amplitude":0,"askPrice":0.285,"askSize":60000,"bidPrice":0.211,"bidSize":20000,"shortable":0,"etf":0,"ttmEps":-0.084305,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1772415000000},"marketStatusCode":0,"adr":0,"listingDate":728841600000,"exchange":"SEHK","adjPreClose":0.26,"openAndCloseTimeList":[[1772155800000,1772164800000],[1772168400000,1772179200000]],"volumeRatio":0,"lotSize":20000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/00660","defaultTab":"news","newsList":[{"id":"2614314058","title":"玮俊生物科技(00660)发布中期业绩,股东应占亏损593.9万港元 同比减少56.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614314058","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614314058?lang=zh_cn&edition=full","pubTime":"2026-02-27 18:24","pubTimestamp":1772187848,"startTime":"0","endTime":"0","summary":"智通财经APP讯,玮俊生物科技(00660)发布截至2025年12月31日止6个月的中期业绩,该公司取得收入3.52亿港元,同比增加118.65%;归属于公司拥有人期内亏损593.9万港元,同比减少56.53%;每股亏损3.33港仙。公告称,收入增加乃由于期间市场消费和需求增加。本集团截至2025年12月31日止6个月取得的毛利及毛利率分别约3570万港元及10.1%,截至2024年12月31日止6个月所取得的毛利约2110万港元及毛利率约13.1%,期间增加约1450万港元及减少3.0%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1408294.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1237","00660"],"gpt_icon":0},{"id":"1164216706","title":"瑋俊生物科技2026财年上半年营收3.52亿元,经调整净亏损0.06亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1164216706","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1164216706?lang=zh_cn&edition=full","pubTime":"2026-02-27 18:21","pubTimestamp":1772187675,"startTime":"0","endTime":"0","summary":"瑋俊生物科技有限公司公布截至2025年12月31日止六个月的中期业绩,报告期内实现营收3.52亿元港币,同比增加118.7%。毛利约0.36亿元港币,较上年同期约0.21亿元港币提高约68.8%,但毛利率从13.1%下降至10.1%。管理层指出,销售费用约0.15亿元港币,同比上升181.9%;行政费用约0.15亿元港币,同比上升22.8%。财务成本则由上年同期约0.10亿元港币降至约0.05亿元港币,主要由于相关债务条款变化带来的利息支出减少。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00660"],"gpt_icon":0},{"id":"2614015641","title":"玮俊生物科技盘中异动 急速下跌7.14%报0.260港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614015641","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614015641?lang=zh_cn&edition=full","pubTime":"2026-02-26 10:27","pubTimestamp":1772072846,"startTime":"0","endTime":"0","summary":"2026年02月26日早盘10时27分,玮俊生物科技股票出现异动,股价快速下跌7.14%。截至发稿,该股报0.260港元/股,成交量0股,换手率0.00%,振幅0.00%。资金方面,该股资金流入1.03万港元,流出0港元。玮俊生物科技股票所在的特殊化工用品行业中,整体涨幅为0.41%。玮俊生物科技公司简介:玮俊生物科技有限公司是一家主要从事制造及销售变性淀粉的香港投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022610272695420769&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022610272695420769&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00660","BK1237"],"gpt_icon":0},{"id":"2614080437","title":"玮俊生物科技(00660.HK):预计中期净亏损不超过600万港元 同比大幅减少","url":"https://stock-news.laohu8.com/highlight/detail?id=2614080437","media":"中金财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614080437?lang=zh_cn&edition=full","pubTime":"2026-02-25 21:37","pubTimestamp":1772026621,"startTime":"0","endTime":"0","summary":"格隆汇2月25日丨玮俊生物科技(00660.HK)公告,根据对集团截至2025年12月31日止六个月未经审核综合管理账目的初步评估,集团预期于截至2025年12月31日止六个月录得之净亏损不超过600万港元,亏损相比截至2024年12月31止六个月之净亏损约1310万港元大幅减少。亏损大幅减少之主要原因为报告期内营业额的上升及财务成本的减少。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260225/32027244.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["00660","BK1237"],"gpt_icon":0},{"id":"1100209115","title":"玮俊生物科技中期业绩预增 主因营收上升与财务成本下降","url":"https://stock-news.laohu8.com/highlight/detail?id=1100209115","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1100209115?lang=zh_cn&edition=full","pubTime":"2026-02-25 21:24","pubTimestamp":1772025845,"startTime":"0","endTime":"0","summary":"玮俊生物科技有限公司(股票代码:00660)预计中期业绩将实现增长。这一积极预期主要得益于公司营收的显著提升以及财务成本的持续下降。营收增长反映了公司核心业务的强劲表现,而财务成本的控制则优化了整体盈利结构。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1237","00660"],"gpt_icon":0},{"id":"1156694708","title":"瑋俊生物科技有限公司2025年下半年营收上升,净利润-6.0百万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1156694708","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1156694708?lang=zh_cn&edition=full","pubTime":"2026-02-25 21:21","pubTimestamp":1772025704,"startTime":"0","endTime":"0","summary":"本期信息\n瑋俊生物科技有限公司(股份代號:660)发布截至2025年12月31日止六个月的中期业绩预告,期内净亏损不超过6.0百万港元,相比2024年同期的约13.1百万港元,亏损幅度大幅收窄。公司方面指出,本期亏损显著减少主要得益于营业额的上升以及财务成本的下降。\n业务分项\n公告中强调,该集团在报告期内营收增长,带动整体业绩改善。同时,财务成本的减少也对盈利能力提升带来正面影响。由于公告未披露其他具体业务板块的营收或经营指标,暂未进一步拆分展示。\n高管解读\n(公告未提供相关高管原话)","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00660"],"gpt_icon":0},{"id":"2614083936","title":"玮俊生物科技(00660)及第一被告已向香港高等法院提交上诉通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2614083936","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614083936?lang=zh_cn&edition=full","pubTime":"2026-02-25 18:53","pubTimestamp":1772016834,"startTime":"0","endTime":"0","summary":"智通财经APP讯,玮俊生物科技 发布公告,于2026年2月13日,本公司接获香港特别行政区高等法院原讼法庭日期为2026年2月13日针对本公司及伟俊集团控股有限公司作出的一项盖印判决书。于本公告日期,本公司及第一被告已向香港高等法院提交上诉通知书。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1407222.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00660","BK1237"],"gpt_icon":0},{"id":"1161867569","title":"玮俊生物科技:法院判决公司及首名被告各向Island Sky支付270万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1161867569","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161867569?lang=zh_cn&edition=full","pubTime":"2026-02-25 18:51","pubTimestamp":1772016674,"startTime":"0","endTime":"0","summary":"根据最新判决,玮俊生物科技有限公司及其首名被告被要求各自向Island Sky支付270万港元。该裁定涉及相关法律纠纷的赔偿事项。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00660","BK1237"],"gpt_icon":0},{"id":"1132665144","title":"玮俊生物科技有限公司正寻求法律咨询以确定潜在行动方案","url":"https://stock-news.laohu8.com/highlight/detail?id=1132665144","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1132665144?lang=zh_cn&edition=full","pubTime":"2026-02-25 18:51","pubTimestamp":1772016669,"startTime":"0","endTime":"0","summary":"玮俊生物科技有限公司日前宣布,公司正在积极寻求专业法律意见,以评估并确定未来可能采取的各项行动。此举旨在为公司的战略决策提供法律依据和可行性分析。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00660","BK1237"],"gpt_icon":0},{"id":"2613712809","title":"玮俊生物科技盘中异动 股价大涨9.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613712809","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613712809?lang=zh_cn&edition=full","pubTime":"2026-02-24 09:36","pubTimestamp":1771897009,"startTime":"0","endTime":"0","summary":"2026年02月24日早盘09时36分,玮俊生物科技股票出现异动,股价大幅上涨9.62%。玮俊生物科技股票所在的特殊化工用品行业中,整体涨幅为0.13%。其相关个股中,玮俊生物科技、上海石油化工股份、中伟新材涨幅较大,振幅较大的相关个股有环球新材国际、国恩科技、上海石油化工股份,振幅分别为11.83%、5.47%、3.70%。玮俊生物科技公司简介:玮俊生物科技有限公司是一家主要从事制造及销售变性淀粉的香港投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022409364997a6c204&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022409364997a6c204&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00660","BK1237"],"gpt_icon":0},{"id":"2610776945","title":"玮俊生物科技(00660.HK)拟2月27日举行董事会会议批准中期业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2610776945","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610776945?lang=zh_cn&edition=full","pubTime":"2026-02-12 17:07","pubTimestamp":1770887227,"startTime":"0","endTime":"0","summary":"格隆汇2月12日丨玮俊生物科技(00660.HK)宣布,公司将于2026年2月27日(星期五)假座香港湾仔港湾道26号华润大厦40楼4001–02室举行董事会会议,藉以考虑及批准(其中包括)公司及其附属公司截至2025年12月31日止六个月的未经审核中期业绩公告及其发布。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260212/32015094.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["00660","BK1237"],"gpt_icon":0},{"id":"2606243826","title":"玮俊生物科技盘中异动 股价大跌8.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606243826","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606243826?lang=zh_cn&edition=full","pubTime":"2026-01-26 11:52","pubTimestamp":1769399578,"startTime":"0","endTime":"0","summary":"2026年01月26日临近午盘11时52分,玮俊生物科技股票出现波动,股价急速下挫8.64%。玮俊生物科技股票所在的特殊化工用品行业中,整体涨幅为0.58%。其相关个股中,环球新材国际、稀美资源、中伟新材涨幅较大,振幅较大的相关个股有稀美资源、环球新材国际、至源控股,振幅分别为18.62%、8.49%、7.69%。玮俊生物科技公司简介:玮俊生物科技有限公司是一家主要从事制造及销售变性淀粉的香港投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126115258a6ac741f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126115258a6ac741f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1237","00660"],"gpt_icon":0},{"id":"2605534854","title":"玮俊生物科技盘中异动 股价大跌5.58%报0.220港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2605534854","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605534854?lang=zh_cn&edition=full","pubTime":"2026-01-21 15:06","pubTimestamp":1768979210,"startTime":"0","endTime":"0","summary":"2026年01月21日下午盘15时06分,玮俊生物科技股票出现异动,股价急速跳水5.58%。截至发稿,该股报0.220港元/股,成交量2万股,换手率0.01%,振幅0.00%。资金方面,该股资金流入4400港元,流出0港元。玮俊生物科技股票所在的特殊化工用品行业中,整体涨幅为0.16%。玮俊生物科技公司简介:玮俊生物科技有限公司是一家主要从事制造及销售变性淀粉的香港投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012115065097a2b76a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012115065097a2b76a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00660","BK1237"],"gpt_icon":0},{"id":"2604916146","title":"玮俊生物科技盘中异动 临近午盘大幅下挫12.07%报0.204港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2604916146","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604916146?lang=zh_cn&edition=full","pubTime":"2026-01-20 11:39","pubTimestamp":1768880355,"startTime":"0","endTime":"0","summary":"2026年01月20日临近午盘11时39分,玮俊生物科技股票出现波动,股价快速跳水12.07%。截至发稿,该股报0.204港元/股,成交量6万股,换手率0.03%,振幅0.00%。玮俊生物科技股票所在的特殊化工用品行业中,整体跌幅为0.45%。其相关个股中,长安仁恒、金源氢化、GHW INTL涨幅较大,振幅较大的相关个股有长安仁恒、帝王实业控股、GHW INTL,振幅分别为11.45%、10.22%、10.00%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260120113915a43f3b05&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260120113915a43f3b05&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00660","BK1237"],"gpt_icon":0},{"id":"1192834342","title":"瑋俊生物科技(660)拟回购最多10%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=1192834342","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1192834342?lang=zh_cn&edition=full","pubTime":"2025-12-05 21:20","pubTimestamp":1764940855,"startTime":"0","endTime":"0","summary":"瑋俊生物科技有限公司于香港联合交易所主板上市。公司公告显示,拟寻求股东大会授权在指定期间内回购不超过其已发行股份总数10%的股份,即最多约17,847,645股。据公告披露,截至最后实际可行日期,公司已发行股份总数为178,476,453股。过去数月,瑋俊生物科技股份价格由2025年1月至11月整体介乎每股0.066港元至0.345港元。为厘定有权出席并投票的股东身份,公司将自2025年12月23日起至12月30日止暂停办理股份过户登记。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00660"],"gpt_icon":0},{"id":"1119563730","title":"瑋俊生物科技(00660)2025年11月股份變動月報表,完成股本面值削減","url":"https://stock-news.laohu8.com/highlight/detail?id=1119563730","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1119563730?lang=zh_cn&edition=full","pubTime":"2025-12-04 16:56","pubTimestamp":1764838566,"startTime":"0","endTime":"0","summary":"瑋俊生物科技有限公司於2025年12月4日發布截至2025年11月30日的股份變動月報表。報告顯示,公司於本月完成普通股及優先股的股本面值削減與拆細,但已發行普通股總數在報告期內維持不變。本次股本結構調整後,公司法定股本總額為102,040,000港元,包括10,000,000,000股普通股及204,000,000股優先股,每股面值均降至0.01港元。公司表示,上述股本面值削減及股份拆細符合香港聯交所《上市規則》及相關法律規定,並由董事會正式批準。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00660"],"gpt_icon":0},{"id":"1148207880","title":"瑋俊生物科技(660)股本重组生效并完成可换股债券条款修订","url":"https://stock-news.laohu8.com/highlight/detail?id=1148207880","media":"公告速递","labels":["corporation","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1148207880?lang=zh_cn&edition=full","pubTime":"2025-11-19 22:16","pubTimestamp":1763561760,"startTime":"0","endTime":"0","summary":"瑋俊生物科技有限公司(660)于2025年11月19日公告,确认其股本重组相关条件已全部达成,获最高法院批准后正式生效。根据公告,新普通股将于2025年11月20日(星期四)上午九时正开始在香港联交所买卖,面值为每股0.01港元。\n紧随股本重组生效,瑋俊生物科技完成了更改现有可换股债券条款的相关交易,该事项亦于同日生效。公司表示,股本重组及上述条款修订不会影响现有股东的任何权利。\n公告还提及,所有现有股份证书仍继续作为股权凭证并可用于交易、结算及登记,因此公司不会安排免费交换股份证书以换取新股份证书。董事会由一名执行董事(主席兼行政总裁)及三名独立非执行董事组成。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00660"],"gpt_icon":0},{"id":"2584997377","title":"玮俊生物科技盘中异动 早盘大幅拉升22.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584997377","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584997377?lang=zh_cn&edition=full","pubTime":"2025-11-19 10:18","pubTimestamp":1763518697,"startTime":"0","endTime":"0","summary":"2025年11月19日早盘10时18分,玮俊生物科技股票出现波动,股价急速拉升22.55%。玮俊生物科技股票所在的特殊化工用品行业中,整体跌幅为0.21%。其相关个股中,玮俊生物科技、环球新材国际、中国三江化工涨幅较大,振幅较大的相关个股有环球新材国际、彩客新能源、GHW INTL,振幅分别为7.53%、6.02%、5.03%。玮俊生物科技公司简介:玮俊生物科技有限公司是一家主要从事制造及销售变性淀粉的香港投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111910181797725ece&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111910181797725ece&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00660","BK1237"],"gpt_icon":0},{"id":"2584067594","title":"玮俊生物科技盘中异动 临近午盘股价大涨6.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584067594","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584067594?lang=zh_cn&edition=full","pubTime":"2025-11-17 11:33","pubTimestamp":1763350400,"startTime":"0","endTime":"0","summary":"2025年11月17日临近午盘11时33分,玮俊生物科技股票出现波动,股价快速上涨6.12%。玮俊生物科技股票所在的特殊化工用品行业中,整体跌幅为0.47%。其相关个股中,保德国际发展、新质数字、玮俊生物科技涨幅较大,振幅较大的相关个股有保德国际发展、新质数字、帝王实业控股,振幅分别为27.45%、17.83%、7.28%。玮俊生物科技公司简介:玮俊生物科技有限公司是一家主要从事制造及销售变性淀粉的香港投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117113320976df863&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117113320976df863&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00660","BK1237"],"gpt_icon":0},{"id":"2580564224","title":"玮俊生物科技盘中异动 股价大跌6.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580564224","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580564224?lang=zh_cn&edition=full","pubTime":"2025-11-03 14:24","pubTimestamp":1762151058,"startTime":"0","endTime":"0","summary":"2025年11月03日下午盘14时24分,玮俊生物科技股票出现波动,股价大幅跳水6.98%。截至发稿,该股报0.200港元/股,成交量9.24万股,换手率0.05%,振幅4.65%。玮俊生物科技股票所在的特殊化工用品行业中,整体涨幅为0.08%。玮俊生物科技公司简介:玮俊生物科技有限公司是一家主要从事制造及销售变性淀粉的香港投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110314241894eb6e4d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110314241894eb6e4d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1237","00660"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.0660.hk","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0.2381},{"period":"3month","weight":0.3472},{"period":"6month","weight":0.3978},{"period":"1year","weight":1.2609},{"period":"ytd","weight":0.383}],"compareEarnings":[{"period":"1week","weight":0.0082},{"period":"1month","weight":-0.043},{"period":"3month","weight":0.0298},{"period":"6month","weight":0.0619},{"period":"1year","weight":0.1228},{"period":"ytd","weight":0.039}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"玮俊生物科技有限公司是一家主要从事制造及销售变性淀粉的香港投资控股公司。该公司连同其附属公司主要从事制造及销售变性淀粉及其他生化产品,例如生化精炼油产品。此外,该公司还从事买卖电子元件、组件和器件及电器。","yearOnYearQuotes":[{"month":1,"riseRate":0.393939,"avgChangeRate":0.06724},{"month":2,"riseRate":0.424242,"avgChangeRate":0.11624},{"month":3,"riseRate":0.30303,"avgChangeRate":0.096707},{"month":4,"riseRate":0.28125,"avgChangeRate":0.037978},{"month":5,"riseRate":0.4375,"avgChangeRate":0.013691},{"month":6,"riseRate":0.515152,"avgChangeRate":0.046961},{"month":7,"riseRate":0.30303,"avgChangeRate":0.024464},{"month":8,"riseRate":0.181818,"avgChangeRate":-0.035696},{"month":9,"riseRate":0.242424,"avgChangeRate":-0.048197},{"month":10,"riseRate":0.34375,"avgChangeRate":0.029107},{"month":11,"riseRate":0.28125,"avgChangeRate":-0.01241},{"month":12,"riseRate":0.212121,"avgChangeRate":-0.037096}],"exchange":"SEHK","name":"玮俊生物科技","nameEN":"WAI CHUN BIOTEC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"玮俊生物科技(00660)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供玮俊生物科技(00660)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"玮俊生物科技,00660,玮俊生物科技股票,玮俊生物科技股票老虎,玮俊生物科技股票老虎国际,玮俊生物科技行情,玮俊生物科技股票行情,玮俊生物科技股价,玮俊生物科技股市,玮俊生物科技股票价格,玮俊生物科技股票交易,玮俊生物科技股票购买,玮俊生物科技股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"玮俊生物科技(00660)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供玮俊生物科技(00660)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}